SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to intense speculation surrounding the upcoming Phase 3 REGAL trial results and ongoing volatility driven by a high short interest position. Community discourse remains deeply polarized, with bulls highlighting the potential for a transformative breakthrough in AML treatment and buyout rumors, while bears express significant skepticism over trial design and the company's long-term sustainability.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing intense community focus as traders speculate on potential short-squeeze dynamics and the possibility of a return to higher price levels. While some participants are actively accumulating in hopes of a rapid rally, others remain cautious, debating whether recent volatility represents a genuine trend reversal or a recurring pump-and-dump cycle.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The software sector is currently experiencing a strong rotation as investors pivot from crowded semiconductor momentum toward enterprise SaaS leaders. The community is actively discussing the sector's 'Agentic AI' monetization potential, debating whether this shift represents a sustainable re-rating or another temporary bounce in a volatile market environment.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is drawing intense retail and institutional scrutiny as investors weigh the significant potential of a looming SpaceX partnership against concerns over debt and massive share sell-offs. The stock is currently being driven by a tug-of-war between aggressive short-sellers betting on further downside and value-focused participants who are betting on a major turnaround fueled by aggressive share buybacks and a potential short squeeze.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The VOO ETF is trending as investors aggressively rotate capital from broad indices into targeted semiconductor and AI memory plays amid fluctuating geopolitical tensions. The market is currently focused on navigating S&P 500 index rebalancing and high-conviction institutional rotation as traders weigh compounding long-term growth against short-term macroeconomic uncertainty.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the announcement of price hikes across its Mac and iPad lines, a move necessitated by soaring memory chip costs that the company can no longer absorb. Community discussions are heavily focused on the implications of these costs, debating whether this signals a broader AI-driven supply crunch or potential demand destruction as consumers face higher prices.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending after reporting its first profitable quarter with strong revenue growth and increased user engagement, signaling a pivotal shift in the company's financial narrative. The community is actively debating the stock's future, highlighting its heavy short interest as a potential catalyst for a squeeze while comparing its growth metrics to fintech peers like Affirm.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following FDA approval of Lumvoa for the treatment of thyroid eye disease, with the community closely tracking the company's immediate commercial launch plans and potential for market share capture. Investors are actively debating the stock's valuation, the competitive landscape against existing treatments, and the prospects for long-term growth as the firm transitions into a commercial-stage entity.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is garnering significant investor interest following its preliminary selection for inclusion in the Russell 3000 and Russell Microcap Indexes, with the community actively speculating on the stock's potential as it positions itself at the intersection of AI, energy, and digital infrastructure. Investors are closely monitoring potential catalysts, such as impending hyperscaler tenant announcements, while discussing the structural demand likely to be generated by index fund rebalancing.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant volatility and intense community debate as investors weigh strong AI-driven memory demand against technical overextension following a massive vertical rally. While bulls point to persistent supply constraints and bullish price target hikes as evidence of a structural supercycle, bearish participants are actively warning of a potential blowoff top and urging caution after the stock's parabolic climb.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MRNA Stock Rallies Over 40% In June: Moderna Bets Its Future On Cancer, Autoimmune Disease And AI-Powered mRNA 

Equity

Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.

Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?

Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business outlook. 


Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more

Here are the companies making headlines in midday trading...

Moderna (MRNA) Rises As Market Takes a Dip: Key Facts

Moderna (MRNA) closed at $61 in the latest trading session, marking a +2.79% move from the prior day.

Should You Buy Moderna Before Aug. 5?

Key PointsInvestors flocked to Moderna during early pandemic days as its coronavirus vaccine delivered blockbuster revenue...

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

Key PointsModera grew revenue by 260% year over year in the first quarter...

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing

Moderna stock gains 3.5% after FDA advisory panel votes 9-0 that mFlusiva's benefits outweigh risks in influenza prevention in older adults, ahead of an Aug. 5 decision.

MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine

Jefferies noted that FDA decisions aligned with advisory committee recommendations 84% of the time between 2020 and 2025.


Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.read more...

MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns

Moderna jumps after FDA briefing documents on mFlusiva appear more constructive than expected ahead of a key advisory panel review.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are hyper-focused on the company's shift toward oncology and T-cell therapies following positive data releases from Science Day.

Massive call buying activity and institutional accumulation are fueling volatile upward price momentum.

Anticipation builds around upcoming FDA decisions for flu vaccines and late-stage clinical readouts in the second half of the year.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$2.06	--	--	N/A
Q1 '26	-$4.45	-$3.40	23.53%	BEAT
Q4 '25	-$2.54	-$2.11	17.07%	BEAT
Q3 '25	-$2.12	-$0.51	75.96%	BEAT
Q2 '25	-$2.96	-$2.13	28.11%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

MRNAModerna Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest MRNA News